Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model
Abstract Left atrial appendage (LAA) closure is being developed as an alternative for stroke prevention in patients with atrial fibrillation that cannot tolerate long-term oral anticoagulation. To assess the feasibility, safety, and performance of a novel modified Occlutech LAA closure device in a p...
Guardado en:
Autores principales: | Markus Reinthaler, Johannes Grosshauser, Tanja Schmidt, Juliane Unger, Ross Morgan, Friederike Zimmermann, Johannes Hartung, Claudio Seppelt, Denitsa Meteva, Wolfram Haider, Ulf Landmesser, Carsten Skurk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/29e4836ee08347ceb7cc73c23b07c720 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Device-Related Thrombus After Left Atrial Appendage Closure
por: Philippe Garot, et al.
Publicado: (2019) -
Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility
por: Swaans MJ, et al.
Publicado: (2016) -
Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP
por: Michael Behnes, et al.
Publicado: (2017) -
Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Toshiaki Isogai, et al.
Publicado: (2021) -
Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
por: Mark S Slaughter, et al.
Publicado: (2021)